Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Altimmune ( (ALT) ) has shared an update.
On April 16, 2026, Altimmune, Inc. held its 2026 Annual Meeting of Stockholders, with 67.8% of the company’s 130.1 million outstanding common shares present or represented by proxy, establishing a quorum for voting. Stockholders re-elected all nine director nominees, affirming the current board composition and maintaining continuity in the company’s leadership.
Investors also ratified the appointment of Ernst & Young LLP as independent auditor for the year ending December 31, 2026, and approved the advisory say-on-pay vote for executive compensation. The meeting further endorsed doubling the company’s authorized common shares to 400 million, expanding the 2019 Employee Stock Purchase Plan share reserve, and authorizing potential adjournment of the meeting to solicit additional proxies, collectively enhancing Altimmune’s capital and compensation flexibility going forward.
The most recent analyst rating on (ALT) stock is a Buy with a $12.00 price target. To see the full list of analyst forecasts on Altimmune stock, see the ALT Stock Forecast page.
Spark’s Take on ALT Stock
According to Spark, TipRanks’ AI Analyst, ALT is a Neutral.
The score is held back primarily by weak financial performance (persistent losses and ongoing cash burn) and bearish technicals (price below key moving averages with negative MACD). Offsetting these are a constructive earnings-call outlook—strong Phase II results, FDA progress, and cash runway into 2028—while valuation signals are limited by a negative P/E and no dividend support in the provided data.
To see Spark’s full report on ALT stock, click here.
More about Altimmune
Altimmune, Inc. is a biopharmaceutical company focused on developing therapies in the life sciences sector, with its common stock actively held and traded by a broad base of stockholders. The company’s governance structure centers on an elected board of directors and relies on equity-based plans to align employee incentives with shareholder interests.
Average Trading Volume: 3,881,246
Technical Sentiment Signal: Sell
Current Market Cap: $442.2M
Find detailed analytics on ALT stock on TipRanks’ Stock Analysis page.